Cargando…
Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma
We aim to find a biomarker that can effectively predict the prognosis of patients with cutaneous melanoma (CM). The RNA sequencing data of CM was downloaded from The Cancer Genome Atlas (TCGA) database and randomly divided into training group and test group. Survival statistical analysis and machine...
Autores principales: | Bai, Haiya, Wang, Youliang, Liu, Huimin, Lu, Junyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320537/ https://www.ncbi.nlm.nih.gov/pubmed/34335689 http://dx.doi.org/10.3389/fgene.2021.680617 |
Ejemplares similares
-
Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020) -
Prognostic Value of Dynactin mRNA Expression in Cutaneous Melanoma
por: Wang, Qiaoqi, et al.
Publicado: (2018) -
The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
por: Wan, Xiaohua, et al.
Publicado: (2017) -
Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
por: Tian, Jun, et al.
Publicado: (2021) -
A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer
por: Zhang, Xiaolu, et al.
Publicado: (2021)